메뉴 건너뛰기




Volumn 62, Issue 8, 2016, Pages 964-971

A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa

(34)  Toure, Offianan Andre a   Valecha, Neena b   Tshefu, Antoinette K c   Thompson, Ricardo d   Krudsood, Srivicha e   Gaye, Oumar f   Rao, Bappanaidu Hoigegudde Krishnamurthy g   Sagara, Issaka h   Bose, Tarit Kumar i   Mohanty, Sanjib j   Rao, Ballamudi Srinivas k   Anvikar, Anupkumar R b   Mwapasa, Victor l   Noedl, Harald m,n   Arora, Sudershan o   Roy, Arjun p   Iyer, Sunil S p   Sharma, Pradeep p   Saha, Nilanjan p   Jalali, Rajinder K p   more..

b India   (India)

Author keywords

artemisinin combination therapy; arterolane maleate; fixed dose combination; malaria; once daily dose

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTEROLANE MALEATE PLUS PIPERAQUINE PHOSPHATE; ASPARTATE AMINOTRANSFERASE; DIHYDROARTEMISININ; HEMOGLOBIN; LIVER ENZYME; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMETHER; ARTEROLANE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PEROXIDE; PIPERAQUINE; QUINOLINE DERIVATIVE; SINGLE HETEROCYCLIC RINGS; SPIRO COMPOUND;

EID: 84964818493     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw029     Document Type: Article
Times cited : (31)

References (23)
  • 3
    • 77954496048 scopus 로고    scopus 로고
    • Malaria control beyond 2010
    • Newman RD. Malaria control beyond 2010. BMJ 2010; 340:c2714.
    • (2010) BMJ , vol.340 , pp. c2714
    • Newman, R.D.1
  • 4
    • 77955491116 scopus 로고    scopus 로고
    • Demand for malaria drug soars
    • Noorden RV. Demand for malaria drug soars. Nature 2010; 466:672-3.
    • (2010) Nature , vol.466 , pp. 672-673
    • Noorden, R.V.1
  • 5
    • 77955951674 scopus 로고    scopus 로고
    • Arterolane, a new synthetic trioxolane for treatment of uncomplicated plasmodium falciparum malaria: A phase II, multicenter, randomized, dose-finding clinical trial
    • Valecha N, Looareesuwan S, Martensson A, et al. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial. Clin Infect Dis 2010; 51:684-91.
    • (2010) Clin Infect Dis , vol.51 , pp. 684-691
    • Valecha, N.1    Looareesuwan, S.2    Martensson, A.3
  • 7
    • 0003484310 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM)
    • Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), 2001.
    • (2001) Guidance for Industry, Bioanalytical Method Validation
  • 8
    • 84864962615 scopus 로고    scopus 로고
    • Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated plasmodium falciparum malaria: A comparative, multicenter, randomized clinical trial
    • Valecha N, Krudsood S, Tangpukdee N, et al. Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial. Clin Infect Dis 2012; 55:663-71.
    • (2012) Clin Infect Dis , vol.55 , pp. 663-671
    • Valecha, N.1    Krudsood, S.2    Tangpukdee, N.3
  • 9
    • 77952303346 scopus 로고    scopus 로고
    • Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated plasmodium falciparum malaria: A randomised non-inferiority trial
    • Tshefu AK, Gaye O, Kayentao K, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010; 375:1457-67.
    • (2010) Lancet , vol.375 , pp. 1457-1467
    • Tshefu, A.K.1    Gaye, O.2    Kayentao, K.3
  • 10
    • 65549137143 scopus 로고    scopus 로고
    • The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
    • Verret WJ, Dorsey G, Nosten F, Price RN. The effect of varying analytical methods on estimates of anti-malarial clinical efficacy. Malar J 2009; 8:77.
    • (2009) Malar J , vol.8 , pp. 77
    • Verret, W.J.1    Dorsey, G.2    Nosten, F.3    Price, R.N.4
  • 11
    • 79959612992 scopus 로고    scopus 로고
    • Geneva, Switzerland: World Health Organization, Accessed 9 February 2016
    • WHO. Global Plan for Artemisinin Resistance Containment (GPARC). Geneva, Switzerland: World Health Organization, 2011. Available at: http://www.who.int/malaria/publications/atoz/artemisinin-resistance-containment-2011.pdf. Accessed 9 February 2016.
    • (2011) Global Plan for Artemisinin Resistance Containment (GPARC)
    • WHO1
  • 13
    • 33748036039 scopus 로고    scopus 로고
    • In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of plasmodium falciparum
    • Maerki S, Brun R, Charman SA, Dorn A, Matile H, Wittlin S. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum. J Antimicrob Chemother 2006; 58:52-8.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 52-58
    • Maerki, S.1    Brun, R.2    Charman, S.A.3    Dorn, A.4    Matile, H.5    Wittlin, S.6
  • 14
    • 38349174133 scopus 로고    scopus 로고
    • Safety, tolerability, and single- and multipledose pharmacokinetics of piperaquine phosphate in healthy subjects
    • Ahmed T, Sharma P, Gautam A, et al. Safety, tolerability, and single- and multipledose pharmacokinetics of piperaquine phosphate in healthy subjects. J Clin Pharmacol 2008; 48:166-75.
    • (2008) J Clin Pharmacol , vol.48 , pp. 166-175
    • Ahmed, T.1    Sharma, P.2    Gautam, A.3
  • 15
    • 80054771436 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. Falciparum malaria
    • Gautam A, Ahmed T, Sharma P, et al. Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria. J Clin Pharmacol 2011; 51:1519-28.
    • (2011) J Clin Pharmacol , vol.51 , pp. 1519-1528
    • Gautam, A.1    Ahmed, T.2    Sharma, P.3
  • 16
    • 77955606614 scopus 로고    scopus 로고
    • An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
    • Valecha N, Phyo AP, Mayxay M, et al. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One 2010; 5:e11880.
    • (2010) PLoS One , vol.5 , pp. e11880
    • Valecha, N.1    Phyo, A.P.2    Mayxay, M.3
  • 17
    • 68149158508 scopus 로고    scopus 로고
    • Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: A prospective multi-centre individual patient data analysis
    • Zwang J, Ashley EA, Karema C, et al. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 2009; 4:e6358.
    • (2009) PLoS One , vol.4 , pp. e6358
    • Zwang, J.1    Ashley, E.A.2    Karema, C.3
  • 18
    • 23244447395 scopus 로고    scopus 로고
    • A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria
    • Ashley EA, McGready R, Hutagalung R, et al. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis 2005; 41:425-32.
    • (2005) Clin Infect Dis , vol.41 , pp. 425-432
    • Ashley, E.A.1    McGready, R.2    Hutagalung, R.3
  • 19
    • 35748964160 scopus 로고    scopus 로고
    • Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria
    • Mytton OT, Ashley EA, Peto L, et al. Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg 2007; 77:447-50.
    • (2007) Am J Trop Med Hyg , vol.77 , pp. 447-450
    • Mytton, O.T.1    Ashley, E.A.2    Peto, L.3
  • 20
    • 34249862105 scopus 로고    scopus 로고
    • Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: A randomized trial
    • Kamya MR, Yeka A, Bukirwa H, et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials 2007; 2:e20.
    • (2007) PLoS Clin Trials , vol.2 , pp. e20
    • Kamya, M.R.1    Yeka, A.2    Bukirwa, H.3
  • 21
    • 0346057805 scopus 로고    scopus 로고
    • Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in cambodian children and adults with malaria
    • Karunajeewa H, Lim C, Hung TY, et al. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 2004; 57:93-9.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 93-99
    • Karunajeewa, H.1    Lim, C.2    Hung, T.Y.3
  • 22
    • 0142209158 scopus 로고    scopus 로고
    • Drug induced QT prolongation and torsades de pointes
    • Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003; 89:1363-72.
    • (2003) Heart , vol.89 , pp. 1363-1372
    • Yap, Y.G.1    Camm, A.J.2
  • 23
    • 35848930611 scopus 로고    scopus 로고
    • Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drugresistant malaria
    • Price RN, Hasugian AR, Ratcliff A, et al. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drugresistant malaria. Antimicrob Agents Chemother 2007; 51:4090-7.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 4090-4097
    • Price, R.N.1    Hasugian, A.R.2    Ratcliff, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.